CareCloud (CCLD) vs Certara (CERT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Certara (CERT) has outperformed CareCloud (CCLD) over the past year, losing 33.5% versus a loss of 44.1%. Over five years, CCLD leads with a -74.1% price change compared with -77.2% for CERT. Certara is the larger company by market cap ($1.32 billion vs $82.4 million), about 16.0 times the size.
On valuation, CareCloud trades at a lower forward P/E (4.3x vs 22.2x for Certara).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCLD | CERT |
|---|---|---|
| Share price | $1.94 | $8.64 |
| Market cap | $82.44M | $1.32B |
| 1-day change | -3.48% | -3.57% |
| YTD return | -33.56% | -1.93% |
| 1-year return | -44.09% | -33.54% |
| 5-year return | -74.10% | -77.17% |
| P/E ratio (TTM) | 32.33 | — |
| Forward P/E | 4.26 | 22.17 |
| EPS (TTM) | $0.06 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.81 | $13.11 |
| 52-week low | $1.93 | $4.45 |
| Distance from 52-week high | -49.08% | -34.10% |
| Analyst consensus | none | buy |
| Avg. price target upside | +277.84% | +0.81% |
| Average volume | 310.70K | 3.10M |
| Shares outstanding | 42.49M | 152.54M |
| Employees | 3,650 | 1,515 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Certara is about 16.0 times larger than CareCloud by market value ($1.32B vs $82.44M).
- CERT has outperformed CCLD by 10.6 percentage points over the past year.
About CareCloud
CCLD stock →CareCloud, Inc., a healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates through Healthcare IT and Medical Practice Management segments.
Technology · Computer Software: Prepackaged Software · 3,650 employees
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Technology · Computer Software: Prepackaged Software · 1,515 employees
CCLD vs CERT FAQ
Which is bigger, CareCloud or Certara?
Certara (CERT) is larger, with a market capitalization of $1.32B compared with $82.44M for CareCloud (CCLD).
Which stock has performed better over the past year, CCLD or CERT?
CERT returned -33.54% over the past 12 months, compared with -44.09% for CCLD (price return, excluding dividends). Past performance does not predict future results.
Are CareCloud and Certara in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.